S&P 500 Falls 1.20% to 5061.82 — Data Talk
The S&P 500 Index is down 61.59 points or 1.20% today to 5061.82
--Down for two consecutive trading days
--Down 137.24 points or 2.64% over the last two trading days
--Largest two-day point decline since Friday, Dec. 16, 2022
--Largest two-day percentage decline since Friday, March 10, 2023
--Down three of the past four trading days
--Off 3.66% from its record close of 5254.35 hit Thursday, March 28, 2024
--Up 50.24% from the Election Day close of 3369.16 on Tuesday, Nov. 3, 2020
--Up 31.41% from the Inauguration Day close of 3851.85 on Wednesday, Jan. 20, 2021
--Lowest closing value since Wednesday, Feb. 21, 2024
--Off 3.66% from its 52-week high of 5254.35 hit Thursday, March 28, 2024
--Up 24.80% from its 52-week low of 4055.99 hit Wednesday, April 26, 2023
--Rose 21.93% from 52 weeks ago
--Off 3.66% from its 2024 closing high of 5254.35 hit Thursday, March 28, 2024
--Up 7.96% from its 2024 closing low of 4688.68 hit Thursday, Jan. 4, 2024
--Month-to-date it is down 3.66%
--Year-to-date it is up 291.99 points or 6.12%
Data based on preliminary market closing values
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 15, 2024 16:31 ET (20:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast